| Financial Year |
March 31 2023 |
| Monetary Funds |
12,957,213,955.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
33,184,909.05 |
| Advances to Suppliers |
273,246,577.99 |
| Other Receivables |
4,561,918,113.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
108,412,914,238.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,996,895,777.95 |
| Other Current Assets |
3,493,797,514.10 |
| Total Current Assets |
131,734,248,355.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,618,180,071.36 |
| Long-term Equity Investment |
5,226,981,276.05 |
| Investment Properties |
362,126,998.21 |
| Fixed Assetes |
116,782,396.72 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,911,749.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
27,211,294.74 |
| Deferred Income Tax Assets |
419,393,485.38 |
| Other Non-Current Assets |
635,074,373.19 |
| Sub-Total of Non-Current Assets |
8,506,258,193.51 |
| Total Assets |
140,240,506,548.89 |
| Short-Term Loans |
2,240,727,805.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
674,655,631.32 |
| Accounts Payable |
13,940,454,547.52 |
| Accounts Received In Advance |
1,636,061.65 |
| Employee Compensation Payable |
177,734,035.23 |
| Taxes Payable |
1,452,141,204.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,812,344,626.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,472,150,210.69 |
| Other Current Liabilities |
2,134,627,442.38 |
| Sub-Total of Current Liabilities |
74,141,236,406.36 |
| Long-term Loans |
23,171,708,602.15 |
| Bonds Payable |
4,587,686,883.50 |
| Long-Term Accounts Payable |
18,549,285,989.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
64,416,286.67 |
| Deferred Income Tax Liabilities |
488,604,879.57 |
| Other Non-Current Liabilities |
410,815,546.77 |
| Sub-Total of Non-Current Liabilities |
47,297,699,070.50 |
| Total Liabilities |
121,438,935,476.86 |
| Paid-In Capital(Or Share Stock) |
695,433,689.00 |
| Capital Surplus |
161,000,488.64 |
| Surplus Reserve |
118,249,106.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,169,142,142.73 |
| Minority Stockholder's Interest |
15,710,578,331.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,090,992,740.21 |
| Owner's Equity（Stockholder's Equity） |
18,801,571,072.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
140,240,506,548.89 |
